Unsupported Browser
The American College of Surgeons website is not compatible with Internet Explorer 11, IE 11. For the best experience please update your browser.
Menu
Become a member and receive career-enhancing benefits

Our top priority is providing value to members. Your Member Services team is here to ensure you maximize your ACS member benefits, participate in College activities, and engage with your ACS colleagues. It's all here.

Become a Member
Become a member and receive career-enhancing benefits

Our top priority is providing value to members. Your Member Services team is here to ensure you maximize your ACS member benefits, participate in College activities, and engage with your ACS colleagues. It's all here.

Become a Member
ACS
Case Study

Decommissioning Centrally Piped Nitrous Oxide: A 96% Cut in Anesthetic Gas Emissions Without Changing Clinical Practice

Stanford Health Care, Palo Alto, California

General Information

Institution Name: Stanford Health Care, Palo Alto, California

Author Name and Title: Eric P. Kraybill, BS, and David Chen, MD, Department of Anesthesiology, Stanford University School of Medicine; Fahmida Bangert, Executive Director, Sustainability Program Office, Stanford Health Care; and Praveen Kalra, MBBS, MD, FASA, Clinical Associate Professor of Anesthesiology, Stanford Medicine, and Medical Director of Sustainability, Stanford Health Care (corresponding author). Misty Komrowski, Sustainability Program Office, assisted in preparing this case study.

Name of Case Study: Decommissioning Centrally Piped Nitrous Oxide: A 96% Cut in Anesthetic Gas Emissions Without Changing Clinical Practice

Identification of Local Problem

Nitrous oxide (N₂O) is a potent greenhouse gas. Its global warming potential is about 298 times that of carbon dioxide, and it stays in the atmosphere for about 114 years. In 2022, N₂O produced 4,590 metric tons CO₂e at Stanford Health Care’s (SHC) Palo Alto campus, about 24% of the campus’s 19,374 metric tons of Scope 1 (direct) emissions.

Most N₂O was delivered through a centrally piped system fed from cryogenic tanks and large cylinders (Figure 1). Comparing purchase records with anesthesia records exposed the problem. In calendar 2022, SHC bought 8,217,449 liters of N₂O for $63,298, but Epic documented only 780,882 liters (9.5%) delivered to patients. The other 90.5%, worth $57,285, was lost to leaks and venting in the delivery system.

Context of the QI Activity

SHC’s sustainability program holds The Joint Commission’s Sustainable Healthcare Certificate of Distinction (2024, the fifth U.S. hospital) and Practice Greenhealth’s Top 25 Environmental Excellence award (2025).

SHC is an academic medical center with multiple surgical campuses. It has pledged, through the U.S. Department of Health and Human Services climate pledge, to cut Scope 1 and 2 emissions by 50% by 2030. The project was led by the Department of Anesthesiology and SHC’s Sustainability Program Office.

The approach follows the American Society of Anesthesiologists’ guidance (Greening the Operating Room, 2023), which recommends abandoning central N₂O pipelines. Health systems in the U.S., U.K., and Australia have reported 77–95% of N₂O lost before clinical use.

It was SHC’s second anesthetic gas initiative. SHC had already removed desflurane, the highest-impact anesthetic gas (global warming potential about 2,540), from its operating rooms, eliminating 434 metric tons of emissions in 2020.

By April 2025, the aim is to reduce N₂O-related Scope 1 emissions by at least 90% across all SHC sites by converting from centrally piped N₂O to point-of-care E cylinders, while maintaining clinician access to N₂O and with no impact on patient care.

Interventions

Centrally piped N₂O was replaced with E cylinders connected directly to each anesthesia machine. N₂O remained available to clinicians; only the delivery method changed.

  • Physical decommissioning: deactivate N₂O alarms at master and area alarm panels and on anesthesia machines; shut off and secure zone valves; remove N₂O outlets and install blank plates; shut off and vent the main manifold and disconnect it from supply tanks.
  • Labeling: “Nitrous Oxide Not in Use” signage at outlets, zone valves, and the main manifold. Piping is abandoned in place and labeled, per the state regulator (HCAI).
  • New workflow: clinicians turn off the E cylinder at the end of each day and back on at the start. A low-pressure alarm on the anesthesia machine at 200 psig (about 95 liters) signals a reorder. The lead anesthesia technician orders and swaps cylinders; where no technicians are available, Biomedical Engineering helps with installation. Backup cylinders are stored in nearby supply closets.

Implementation Strategy

The team used the Institute for Healthcare Improvement’s Plan-Do-Study-Act model. The enterprise team spanned Anesthesiology, OR leadership, anesthesia technicians, Facilities, Biomedical Engineering, Environmental Health and Safety (EH&S), Regulatory Affairs, Infection Prevention and Control, and the Sustainability Program Office as the convener.

Key approvals: SHC’s Cost Savings Reinvestment Program (May 2023), the sustainability Steering Committee (December 2023), and the state regulator, HCAI (final approval October 2024). Interventional Platform leadership endorsed the change before it was communicated to anesthesia faculty.

At each site, the conversion followed four steps:

  • Measure the loss. Compare N₂O purchase volumes with delivery documented in Epic (SlicerDicer), by clinical service. Each group gathers its own data: the OR director inventories cylinders, anesthesia machines, and space; anesthesiology pulls clinical use by location and clinician; Facilities and Sustainability inventory wall outlets, pull procurement data, and calculate emissions and percent lost.
  • Pilot and verify. Disconnect the central pipelines and run E cylinders only. Weigh each cylinder weekly (1 lb N₂O = 247.5 liters; Figure 2) and compare the weights with Epic delivery data.
  • Establish portable supply. Set par levels, storage, ordering roles, and staff education.
  • Decommission with hard controls at each step: a Joint Commission standard risk assessment and lock-out/tag-out (LOTO) procedure; supply side (central manifold and zone isolation valves); demand side (wall and machine outlets); and alarms (medical gas system and anesthesia machine alarms).
Site Pilot Converted
Redwood City (8 ORs) June 26 – July 31, 2023 November 2023
875 Blake Wilbur (16 ORs) January 6–27, 2024 April 2024
300 Pasteur — November 2024
500 Pasteur — April 26–27, 2025
Site Pilot Converted
Redwood City (8 ORs) June 26 – July 31, 2023 November 2023
875 Blake Wilbur (16 ORs) January 6–27, 2024 April 2024
300 Pasteur — November 2024
500 Pasteur — April 26–27, 2025

Safety and regulatory steps:

  • EH&S walked every affected room and confirmed cylinder storage locations. In a patient care area, storing more than 12 cylinders or more than 300 cubic feet of gas requires approval from the authority having jurisdiction.
  • The project was submitted for state regulatory (HCAI) review. Decommissioning was timed to follow certification of in-flight construction projects, and future construction submittals remove piped N₂O from scope.
  • No utility shutdowns were required.

Costs and Funding Sources

The conversion was essentially cost-neutral and was funded from existing operating budgets. No construction was required. Existing facilities and anesthesia teams did the work with SHC’s medical gas vendor, whose one-time services (alarm panel reprogramming and outlet blank plates) were the main expense.

Ongoing costs fall because far less N₂O is purchased and E cylinders are cheaper per unit than bulk supply. Across the four sites, annual N₂O costs fell from about $66,000 to about $4,000 (about 94%). At 875 Blake Wilbur, for example, cylinder costs fell from $615 (liquid dewar) to $35 (E cylinder). Purchase quantities must still cover a small surplus and spare cylinders.

figure1500ptankfarm.jpg

Figure 1: Liquid nitrous oxide dewars at the 500 Pasteur tank farm, which supplied the central pipeline before conversion.

figure2technicianweighingecylinder.png

Figure 2: Anesthesia technician Mariano Garcia removing an E cylinder for weighing during the 875 Blake Wilbur pilot.

Overall Results and Analysis

The pilots showed that Epic documentation accurately measures N₂O use, and the enterprise rollout showed that nearly all of the loss could be eliminated.

Measurement was validated. In both pilots, weighed cylinder use closely matched Epic documentation (Figure 3):

Pilot Weighed use (L) Epic documented (L)
Redwood City, 8 ORs, 5 weeks 1,831.5 1,839.3
875 Blake Wilbur, 16 ORs, 3 weeks 2,574 2,840.3
Pilot Weighed use (L) Epic documented (L)
Redwood City, 8 ORs, 5 weeks 1,831.5 1,839.3
875 Blake Wilbur, 16 ORs, 3 weeks 2,574 2,840.3

Across both pilots, total use was less than three E cylinders (1 E cylinder = 1,590 liters). Leak losses were almost completely eliminated (Figure 4), with no detriment to patient care.

Enterprise results. The four sites accounted for 100% of N₂O use across SHC-owned facilities. After conversion, N₂O-related Scope 1 emissions fell by about 96% from the 2022 baseline of 4,590 metric tons CO₂e. Annual savings total about $62,482:

Site N₂O emissions reduction Savings (USD/yr)
500 Pasteur 97% $38,846
300 Pasteur 93% $11,134
875 Blake Wilbur 96% $9,748
Redwood City 80% $2,754
Total 96% $62,482
Site N₂O emissions reduction Savings (USD/yr)
500 Pasteur 97% $38,846
300 Pasteur 93% $11,134
875 Blake Wilbur 96% $9,748
Redwood City 80% $2,754
Total 96% $62,482

Together with SHC’s other emissions projects, this work contributed to a 53% reduction in Scope 1 and 2 emissions. As a result, SHC raised its 2030 target from a 50% to a 75% reduction.

No N₂O delivery issues or case delays have been reported since conversion, and SHC has had no N₂O supply shortages. Because N₂O use in clinical care is now low, cylinder availability has not constrained practice.

Figure 3: N₂O measured from E cylinders closely tracked Epic documentation during the 875 Blake Wilbur pilot (16 procedure rooms, January 6–27, 2024).

figure4jmiremissionscentralvsportable.png

Figure 4: Estimated annual N₂O emissions at the two pilot sites before and after conversion: 875 Blake Wilbur fell 96% (787 to 28 mtCO₂e) and Redwood City 80% (87 to 19 mtCO₂e). Source: Kraybill EP, Chen D, Khan S, Kalra P. JMIR Perioper Med 2025;8:e64921. doi:10.2196/64921. Licensed under CC BY 4.0.

Limitations

  • Enterprise emissions and savings are estimated from purchase and delivery records, not direct measurement of leaks.
  • Pilot scales measured only to 0.1 lb, and both scale readings and Epic documentation are subject to human error.
  • E cylinders can still leak if valves are left open, until the valve is closed or the cylinder is empty. End-of-day shutoff was not formally audited; in practice, many cylinders are never opened because N₂O use is now so low.
  • Pilots ran 3 to 5 weeks; real-world use may vary from pilot conditions.
  • Cylinder storage is limited by fire and life-safety code, so each site needs its own space and code review.
  • Benefits scale with N₂O volume. At small, low-use sites, the emissions and cost gains may not justify the effort of conversion.
  • Results come from a single health system.

Lessons Learned

  • Bring in EH&S and regulatory teams early. Cylinder storage limits and coordination with active construction projects set the timeline more than the physical work did.
  • Block the pipes during a pilot. At 875 Blake Wilbur, one OR’s pipeline was accidentally reconnected during the first week. The issue was caught and fixed within a week, but most of that pilot’s measurement error came from week one. Physically blocking piped outlets and using higher-precision scales avoids this.
  • Start small and sequence. A lower-volume pilot site-built confidence and produced a reusable playbook (risk assessment, LOTO procedure, regulatory submittal, workflow) for larger hospitals.
  • The EHR can size the opportunity. At Redwood City, Epic matched weighed cylinder use within 0.4%. Comparing N₂O purchased with N₂O documented is a fast, credible way for any hospital to measure its loss. Normalizing emissions per OR per year helps benchmark sites and prioritize the largest.
  • Fix the infrastructure, not the clinician. Because N₂O stayed available and practice barely changed, clinicians had little reason to resist. This made adoption far easier than projects that change clinical workflow.
  • It replicates. The same playbook worked at an outpatient center, an ambulatory surgery center, and two hospitals. SHC is now extending it to its Tri-Valley campuses

Acknowledgements

The authors thank Helen Wilmot, Senior Vice President, Chief Facilities Services, Stanford Health Care, for executive sponsorship of this work. We thank Saadat Khan, former Sustainability Energy Engineer, Sustainability Program Office, who was instrumental in providing project management and engineering support. We also thank Dr. Rachel Outterson, Medical Director, Redwood City; Dale Mark, Lead Anesthesia Technician; anesthesia technician Mariano Garcia; Michael Cunha, Facilities Field Services; and Krunal Rathod, Manager, Systems Engineering. We are grateful for the support of Dr. Sam Wald, Chief Perioperative, Pharmacy & Imaging Officer; and Dr. Brian Bateman, Chair, Department of Anesthesiology, Perioperative and Pain Medicine.

Related Publication

Kraybill EP, Chen D, Khan S, Kalra P. Reducing Greenhouse Gas Emissions and Modifying Nitrous Oxide Delivery at Stanford: Observational, Pilot Intervention Study. JMIR Perioper Med 2025;8:e64921. doi:10.2196/64921. https://periop.jmir.org/2025/1/e64921